Lysosomal acid lipase deficiency: A form of non-obese fatty liver disease (NOFLD)

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: With the growing obesity epidemic, nonalcoholic fatty liver disease (NAFLD) is rapidly becoming one of the leading causes of liver disease worldwide. Although obesity is a main risk factor for the development of NAFLD, it can also develop in lean subjects and can be encountered in different clinical setting and in association with an array of genetic, metabolic, nutritional, infectious and drug-induced disorders. Areas covered: This article discusses causes of fatty liver in non-obese subjects focusing on Lysosomal acid lipase deficiency (LAL-D), a commonly overlooked disorder reviewing its prevalence, genetics, pathogenesis, clinical features, diagnosis and treatment. It will also review other causes of non-alcoholic fatty liver disease, which can be encountered in the absence of obesity and metabolic syndrome. Expert commentary: Although the prevalence of LAL-D has been estimated in the range of 1 in 40,000 and 1 in 300,000, this estimate is much more than the identified cases reported in the literature, which suggests that that the disease may be considerably under-diagnosed. There is a pressing need to educate clinicians about the disease, especially with the development of new promising therapeutic modalities.

Original languageEnglish (US)
Pages (from-to)911-924
Number of pages14
JournalExpert Review of Gastroenterology and Hepatology
Volume11
Issue number10
DOIs
StatePublished - Jan 1 2017

Fingerprint

Fatty Liver
Liver Diseases
Obesity
Nutrigenomics
Therapeutics
Pharmaceutical Preparations
Lysosomal acid lipase deficiency
Non-alcoholic Fatty Liver Disease

Keywords

  • LAL-D
  • Lysosomal acid lipase deficiency
  • Metabolic syndrome
  • NAFLD
  • NASH
  • NOFLD
  • Nonalcoholic fatty liver disease
  • Obesity

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Lysosomal acid lipase deficiency : A form of non-obese fatty liver disease (NOFLD). / Hassan, Hassan H.

In: Expert Review of Gastroenterology and Hepatology, Vol. 11, No. 10, 01.01.2017, p. 911-924.

Research output: Contribution to journalReview article

@article{d05e9ac19e72439c9b29c3be2d7d625e,
title = "Lysosomal acid lipase deficiency: A form of non-obese fatty liver disease (NOFLD)",
abstract = "Introduction: With the growing obesity epidemic, nonalcoholic fatty liver disease (NAFLD) is rapidly becoming one of the leading causes of liver disease worldwide. Although obesity is a main risk factor for the development of NAFLD, it can also develop in lean subjects and can be encountered in different clinical setting and in association with an array of genetic, metabolic, nutritional, infectious and drug-induced disorders. Areas covered: This article discusses causes of fatty liver in non-obese subjects focusing on Lysosomal acid lipase deficiency (LAL-D), a commonly overlooked disorder reviewing its prevalence, genetics, pathogenesis, clinical features, diagnosis and treatment. It will also review other causes of non-alcoholic fatty liver disease, which can be encountered in the absence of obesity and metabolic syndrome. Expert commentary: Although the prevalence of LAL-D has been estimated in the range of 1 in 40,000 and 1 in 300,000, this estimate is much more than the identified cases reported in the literature, which suggests that that the disease may be considerably under-diagnosed. There is a pressing need to educate clinicians about the disease, especially with the development of new promising therapeutic modalities.",
keywords = "LAL-D, Lysosomal acid lipase deficiency, Metabolic syndrome, NAFLD, NASH, NOFLD, Nonalcoholic fatty liver disease, Obesity",
author = "Hassan, {Hassan H}",
year = "2017",
month = "1",
day = "1",
doi = "10.1080/17474124.2017.1343144",
language = "English (US)",
volume = "11",
pages = "911--924",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "10",

}

TY - JOUR

T1 - Lysosomal acid lipase deficiency

T2 - A form of non-obese fatty liver disease (NOFLD)

AU - Hassan, Hassan H

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Introduction: With the growing obesity epidemic, nonalcoholic fatty liver disease (NAFLD) is rapidly becoming one of the leading causes of liver disease worldwide. Although obesity is a main risk factor for the development of NAFLD, it can also develop in lean subjects and can be encountered in different clinical setting and in association with an array of genetic, metabolic, nutritional, infectious and drug-induced disorders. Areas covered: This article discusses causes of fatty liver in non-obese subjects focusing on Lysosomal acid lipase deficiency (LAL-D), a commonly overlooked disorder reviewing its prevalence, genetics, pathogenesis, clinical features, diagnosis and treatment. It will also review other causes of non-alcoholic fatty liver disease, which can be encountered in the absence of obesity and metabolic syndrome. Expert commentary: Although the prevalence of LAL-D has been estimated in the range of 1 in 40,000 and 1 in 300,000, this estimate is much more than the identified cases reported in the literature, which suggests that that the disease may be considerably under-diagnosed. There is a pressing need to educate clinicians about the disease, especially with the development of new promising therapeutic modalities.

AB - Introduction: With the growing obesity epidemic, nonalcoholic fatty liver disease (NAFLD) is rapidly becoming one of the leading causes of liver disease worldwide. Although obesity is a main risk factor for the development of NAFLD, it can also develop in lean subjects and can be encountered in different clinical setting and in association with an array of genetic, metabolic, nutritional, infectious and drug-induced disorders. Areas covered: This article discusses causes of fatty liver in non-obese subjects focusing on Lysosomal acid lipase deficiency (LAL-D), a commonly overlooked disorder reviewing its prevalence, genetics, pathogenesis, clinical features, diagnosis and treatment. It will also review other causes of non-alcoholic fatty liver disease, which can be encountered in the absence of obesity and metabolic syndrome. Expert commentary: Although the prevalence of LAL-D has been estimated in the range of 1 in 40,000 and 1 in 300,000, this estimate is much more than the identified cases reported in the literature, which suggests that that the disease may be considerably under-diagnosed. There is a pressing need to educate clinicians about the disease, especially with the development of new promising therapeutic modalities.

KW - LAL-D

KW - Lysosomal acid lipase deficiency

KW - Metabolic syndrome

KW - NAFLD

KW - NASH

KW - NOFLD

KW - Nonalcoholic fatty liver disease

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=85054426863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054426863&partnerID=8YFLogxK

U2 - 10.1080/17474124.2017.1343144

DO - 10.1080/17474124.2017.1343144

M3 - Review article

C2 - 28612634

AN - SCOPUS:85054426863

VL - 11

SP - 911

EP - 924

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 10

ER -